Effect of Repeated Exposures to Compressed Air on Patients With AIDS
NCT00444847 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2017-07-27
Summary
The exposure of human beings to markedly altered environments (ambient pressure and inhaled gas mixtures) has profound effects on their innate immune capacity to effectively combat viral illnesses. This Phase IIA clinical trial examines the effects of an exposure to a 4 atmospheric environment has on HIV-infected humans whose clinical condition has progressed to formal AIDS status.
Conditions
- AIDS
Interventions
- DEVICE
-
Hyperbaric chamber
Sponsors & Collaborators
-
Designed Altobaric Technology, Incorporated
lead OTHER
Principal Investigators
-
Stephen D. Guthrie, MD, PhD · Designed Altobaric Environment Technology
-
Stephen G Guthrie, MD, PhD · Designed Altobaric Environment Technology
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-07-31
Countries
- United States
Study Locations
More Related Trials
-
The Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3
NCT00000825 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects
NCT01428596 ·Status: UNKNOWN ·Phase: PHASE1
-
Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients
NCT00058734 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the Safety and Immune Response to an HIV Vaccine Boost Following the Administration of Two HIV Vaccines, in HIV-Uninfected, Healthy Adults (Study Extension to HVTN 073/SAAVI 102)
NCT01423825 ·Status: COMPLETED ·Phase: PHASE1
-
Vaccine Treatment for HIV-Infection
NCT00108654 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Effectiveness of Anti-HIV Vaccines in HIV-Negative Adults
NCT00000904 ·Status: COMPLETED ·Phase: PHASE1
-
Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 704/HPTN 085 AMP Study
NCT04801758 ·Status: COMPLETED ·Phase: NA
-
Safety of and Immune Response to Two Different HIV Vaccines, Each Followed by a Adenoviral Vaccine Boost, in HIV Uninfected Adults
NCT00270218 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Study of IL-7 in HIV-infected Patients (Inspire)
NCT00477321 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy Adults
NCT00472719 ·Status: COMPLETED ·Phase: PHASE1
-
The Effects of r-metHuIFN-Gamma on the Lungs of Patients With AIDS
NCT00002433 ·Status: COMPLETED ·Phase: NA
-
A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy
NCT00000820 ·Status: COMPLETED ·Phase: PHASE2
-
HIV-1 Vaccine Booster in Previously Immunized Uninfected Adult Volunteers
NCT00102089 ·Status: COMPLETED ·Phase: PHASE1
-
Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte (CTL) Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 Infection
NCT00000875 ·Status: TERMINATED ·Phase: NA
-
Evaluation of the Safety and Tolerance of Immunotherapy With Autologous, Ex-Vivo Expanded, HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4+ Counts Between 100-400/mm3
NCT00000756 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3
NCT00000948 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial of Anti-CD4 Antibody UB-421 in Combination With Optimized Background Antiretroviral Therapy in Patients With Multi-Drug Resistant HIV-1 Infection
NCT05582694 ·Status: WITHDRAWN ·Phase: PHASE2
-
Safety of the Candidate Vaccine C4-V3 Alone or With Interleukin-12 (IL-12) in HIV-Infected Patients Receiving Effective Anti-HIV Drug Therapy
NCT00005779 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety and Immunogenicity of an Oral HIV Vaccine in Healthy, HIV-uninfected Adults
NCT02771730 ·Status: TERMINATED ·Phase: PHASE1
-
Immune Responses to Two Experimental HIV Vaccines in Healthy Adults
NCT01386489 ·Status: COMPLETED ·Phase: PHASE1
-
The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women
NCT00006444 ·Status: COMPLETED
-
A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Three Preparations of Low-Dose Oral Alpha Interferon in HIV-Infected Patients With CD4+ Counts >= 50 and <= 350 Cells/mm3
NCT00000844 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection
NCT00002441 ·Status: COMPLETED ·Phase: PHASE3
-
Safety of and Immune Response to a Combination HIV Vaccine Regimen in HIV Uninfected Adults
NCT00073216 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Tolerability of AAV8 Delivery of a Broadly Neutralizing Antibody in Adults Living With HIV: a Phase 1, Dose-escalation Trial
NCT03374202 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1